Roussos, George http://orcid.org/0000-0002-7665-7303
Herrero, Teresa Ruiz
Hill, Derek L. http://orcid.org/0000-0003-1970-1432
Dowling, Ariel V. http://orcid.org/0000-0002-7889-4978
L. T. M. Müller, Martijn
Evers, Luc J. W.
Burton, Jackson
Derungs, Adrian
Fisher, Katherine
Kilambi, Krishna Praneeth http://orcid.org/0000-0003-4848-2611
Mehrotra, Nitin
Bhatnagar, Roopal
Sardar, Sakshi
Stephenson, Diane
Adams, Jamie L.
Ray Dorsey, E. http://orcid.org/0000-0002-5140-1248
Cosman, Josh http://orcid.org/0000-0003-3320-4053
Article History
Received: 21 October 2021
Accepted: 29 June 2022
First Online: 15 July 2022
Competing interests
: D.S., M.M., R.B., S.S., J.B. (at time of writing at C-Path): No competing interests to declare. G.R.: is a technical advisor to the Critical Path for Parkinson’s Consortium (CPP). T.R.H.: at time of writing Project Lead of Digital and Quantitative Medicine at Biogen. D.H.: is President of Panoramic Digital Health. A.V.D.: is Director of Digital Strategy at Takeda. J.C.: is Director of Digital Health Strategy at AbbVie and Industry Co-Director of CPP. L.E.: has received funding from the Michael J Fox Foundation for Parkinson’s Research, UCB Biopharma, Stichting ParkinsonFonds, the Dutch Ministry of Economic Affairs, and ZonMw. A.D.: is Digital Biomarker Sensor Lead & Senior Scientist at Roche. K.F.: at time of writing Senior Director of Digital and Quantitative Medicine at Biogen. K.P.K.: Scientist at Biogen. N.M.: at time of writing Senior Principal Scientist of Quantitative Pharmacology and Pharmacometrics at Merck. R.D.: has stock ownership in Grand Rounds, an online second opinion service, has received consultancy fees from 23andMe, Abbott, Abbvie, Amwell, Biogen, Clintrex, CuraSen, DeciBio, Denali Therapeutics, GlaxoSmithKline, Grand Rounds, Huntington Study Group, Informa Pharma Consulting, medical-legal services, Mednick Associates, Medopad, Olson Research Group, Origent Data Sciences, Inc., Pear Therapeutics, Prilenia, Roche, Sanofi, Shire, Spark Therapeutics, Sunovion Pharmaceuticals, Voyager Therapeutics, ZS Consulting, honoraria from Alzheimer’s Drug Discovery Foundation, American Academy of Neurology, American Neurological Association, California Pacific Medical Center, Excellus BlueCross BlueShield, Food and Drug Administration, MCM Education, The Michael J Fox Foundation, Stanford University, UC Irvine, University of Michigan, and research funding from Abbvie, Acadia Pharmaceuticals, AMC Health, BioSensics, Burroughs Wellcome Fund, Greater Rochester Health Foundation, Huntington Study Group, Michael J. Fox Foundation, National Institutes of Health, Nuredis, Inc., Patient-Centered Outcomes Research Institute, Pfizer, Photopharmics, Roche, Safra Foundation. J.A.: has received honoraria from Huntington Study Group, research support from National Institutes of Health, The Michael J Fox Foundation, Biogen, Safra Foundation, Empire Clinical Research Investigator Program, and consultancy fees from VisualDx and Spark Therapeutics.